|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
149,990,000 |
Market
Cap: |
137.98(M) |
Last
Volume: |
394,168 |
Avg
Vol: |
182,008 |
52
Week Range: |
$0.9199 - $0.9199 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
6,836,925 |
6,836,925 |
6,836,925 |
Total Buy Value |
$0 |
$7,110,902 |
$7,110,902 |
$7,110,902 |
Total People Bought |
0 |
3 |
3 |
3 |
Total Buy Transactions |
0 |
4 |
4 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Broadwood Capital Inc |
10% Owner |
|
2013-12-30 |
4 |
B |
$3.49 |
$610,750 |
D/D |
175,000 |
9,322,262 |
2.45 |
- |
|
Broadwood Capital Inc |
10% Owner |
|
2013-12-27 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,147,262 |
1.42 |
- |
|
Broadwood Capital Inc |
10% Owner |
|
2013-12-27 |
4 |
B |
$3.53 |
$197,680 |
D/D |
56,000 |
9,147,262 |
2.45 |
- |
|
Broadwood Capital Inc |
10% Owner |
|
2013-12-26 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,091,262 |
1.42 |
- |
|
Broadwood Capital Inc |
10% Owner |
|
2013-12-26 |
4 |
B |
$3.53 |
$243,718 |
D/D |
69,042 |
9,091,262 |
2.45 |
- |
|
Tew William P Phd |
Chief Commercial Officer |
|
2013-11-20 |
4 |
S |
$3.73 |
$14,400 |
D/D |
(3,860) |
33,265 |
|
- |
|
Tew William P Phd |
Chief Commercial Officer |
|
2013-11-18 |
4 |
S |
$3.76 |
$37,659 |
D/D |
(10,000) |
37,125 |
|
- |
|
Farrell Stephen C |
Director |
|
2013-09-12 |
4 |
B |
$3.86 |
$11,276 |
D/D |
2,922 |
15,400 |
2.39 |
- |
|
Farrell Stephen C |
Director |
|
2013-09-11 |
4 |
B |
$3.90 |
$32,327 |
D/D |
8,291 |
12,478 |
2.39 |
- |
|
Berger Franklin M |
Director |
|
2013-08-20 |
4 |
B |
$3.71 |
$1,855 |
D/D |
500 |
500 |
2.31 |
- |
|
Farrell Stephen C |
Director |
|
2013-08-20 |
4 |
B |
$3.66 |
$9,878 |
D/D |
2,700 |
4,187 |
2.39 |
- |
|
Farrell Stephen C |
Director |
|
2013-08-19 |
4 |
B |
$3.65 |
$5,422 |
D/D |
1,487 |
1,487 |
2.39 |
- |
|
Von Eschenbach Andrew C. |
Director |
|
2013-08-12 |
4 |
B |
$3.69 |
$11,070 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
Bradsher Neal C |
Director |
|
2013-06-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,022,220 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2013-06-04 |
4 |
B |
$0.00 |
$0 |
D/D |
200,000 |
9,022,220 |
3.84 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2013-06-04 |
4 |
S |
$0.00 |
$0 |
D/D |
(320,000) |
6,620,055 |
|
- |
|
Lichtinger Pedro |
Director |
|
2013-06-04 |
4 |
B |
$0.00 |
$0 |
D/D |
120,000 |
126,250 |
2.31 |
- |
|
Bradsher Neal C |
Director |
|
2013-03-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,822,220 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2013-03-28 |
4 |
B |
$3.81 |
$762,000 |
D/D |
200,000 |
8,822,220 |
3.92 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2013-03-28 |
4 |
S |
$3.81 |
$762,000 |
D/D |
(200,000) |
7,090,055 |
|
- |
|
Greenbelt Corp /ny |
10% Owner |
|
2013-01-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
55,100 |
1,627,405 |
|
- |
|
Kingsley Alfred D |
See Remarks |
|
2012-12-14 |
4 |
D |
$4.34 |
$249,414 |
D/D |
(57,511) |
7,110,055 |
|
- |
|
Greenway Partners L P |
10% Owner |
|
2012-12-14 |
4 |
D |
$4.34 |
$498,827 |
D/D |
(115,022) |
375,351 |
|
- |
|
Bradsher Neal C |
Director |
|
2012-11-15 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,622,220 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2012-11-15 |
4 |
B |
$2.90 |
$1,000,001 |
D/D |
344,828 |
8,622,220 |
3.92 |
- |
|
412 Records found
|
|
Page 9 of 17 |
|
|